Genesee Capital Advisors LLC raised its holdings in shares of Oscar Health, Inc. (NYSE:OSCR – Free Report) by 227.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 44,338 shares of the company’s stock after purchasing an additional 30,814 shares during the quarter. Genesee Capital Advisors LLC’s holdings in Oscar Health were worth $1,367,000 at the end of the most recent reporting period.
A number of other large investors have also recently made changes to their positions in the stock. Abel Hall LLC grew its holdings in shares of Oscar Health by 4.0% in the third quarter. Abel Hall LLC now owns 10,376 shares of the company’s stock worth $320,000 after purchasing an additional 400 shares during the last quarter. Vontobel Holding Ltd. bought a new stake in Oscar Health during the 3rd quarter valued at about $524,000. TD Waterhouse Canada Inc. lifted its holdings in Oscar Health by 16.7% during the 3rd quarter. TD Waterhouse Canada Inc. now owns 13,350 shares of the company’s stock valued at $399,000 after buying an additional 1,907 shares in the last quarter. North Capital Inc. bought a new stake in Oscar Health during the 3rd quarter valued at about $319,000. Finally, Assenagon Asset Management S.A. boosted its position in Oscar Health by 107.5% in the 3rd quarter. Assenagon Asset Management S.A. now owns 2,589,708 shares of the company’s stock valued at $79,867,000 after buying an additional 1,341,716 shares during the period. 75.70% of the stock is owned by hedge funds and other institutional investors.
Insider Activity at Oscar Health
In other Oscar Health news, insider Adam Mcananey sold 9,092 shares of the stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total transaction of $285,943.40. Following the sale, the insider owned 209,004 shares of the company’s stock, valued at approximately $6,573,175.80. This trade represents a 4.17% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Richard Blackley sold 28,869 shares of Oscar Health stock in a transaction on Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total value of $907,930.05. Following the completion of the transaction, the chief financial officer owned 1,046,108 shares in the company, valued at $32,900,096.60. This represents a 2.69% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 874,451 shares of company stock valued at $26,761,671 over the last 90 days. Insiders own 22.64% of the company’s stock.
Analyst Ratings Changes
A number of equities analysts have commented on OSCR shares. The Goldman Sachs Group restated a “neutral” rating and issued a $34.00 target price on shares of Oscar Health in a research note on Thursday, September 17th. Bank of America lifted their price target on shares of Oscar Health from $28.00 to $30.00 and gave the company an “underperform” rating in a research note on Thursday, September 17th. UBS Group lifted their price target on shares of Oscar Health from $26.00 to $36.00 and gave the company a “neutral” rating in a research note on Monday, October 12th. Stephens reiterated an “equal weight” rating and issued a $34.00 price target on shares of Oscar Health in a report on Thursday, September 17th. Finally, Raymond James Financial increased their price objective on Oscar Health from $34.00 to $42.00 and gave the stock an “outperform” rating in a research note on Friday, September 18th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average price target of $34.90.
Get Our Latest Research Report on Oscar Health
Oscar Health Stock Up 4.0%
Oscar Health stock traded up $1.31 during midday trading on Tuesday, hitting $33.85. 1,639,564 shares of the company’s stock were exchanged, compared to its average volume of 6,794,465. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.09 and a current ratio of 1.09. Oscar Health, Inc. has a 12 month low of $10.69 and a 12 month high of $35.01. The firm has a 50-day moving average of $31.57 and a two-hundred day moving average of $26.86. The company has a market cap of $10.45 billion, a PE ratio of 24.15, a P/E/G ratio of 0.35 and a beta of 2.47.
Oscar Health (NYSE:OSCR – Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported $1.10 EPS for the quarter, beating analysts’ consensus estimates of $0.40 by $0.70. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The business had revenue of $4.88 billion for the quarter, compared to the consensus estimate of $4.73 billion. During the same quarter last year, the firm posted ($0.89) EPS. The company’s revenue for the quarter was up 70.4% on a year-over-year basis. As a group, analysts expect that Oscar Health, Inc. will post 1.83 earnings per share for the current fiscal year.
Oscar Health Profile
Oscar Health, Inc is a technology-focused health insurance company that provides health plans and related services in the United States. The company primarily serves individuals and families purchasing coverage through the Affordable Care Act’s health insurance marketplace, as well as small businesses and their employees.
Oscar combines health insurance products with digital tools designed to help members manage their care. Its services include online enrollment, virtual care, provider search and appointment support, care navigation, claims and benefits information, and member engagement through web and mobile applications.
Featured Articles
- Five stocks we like better than Oscar Health
- Meta Platforms’ AI Comeback Faces an Earnings Test—And a $10 Billion Charge
- IonQ’s Bold Expansion Could Leave Shareholders Paying the Price
- Powering Up: Applied Digital Execs Buy $6.7M in Stock
- Chip Stocks Are Sliding—Why Is Smart Money Buying?
Want to see what other hedge funds are holding OSCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR – Free Report).
Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.
